Comparison of the tumor markers CEA, TPA, and CA 19-9 in colorectal carcinoma
- 15 January 1987
Abstract
In 103 patients with colorectal carcinoma carcinogenic antigen, 19‐9 (CEA), tissue polypeptide (TPA) and carbohydrate antigen (CA 19–9) were measured in serum. The values determined in these patients and in a control group have been converted into specificity‐sensitivity diagrams. Comparison of diagrams of the three markers showed that CEA has the greatest sensitivity in colorectal carcinoma. Different ways to enhance the sensitivity by combination of the markers have been tried. By combination, however, the sensitivity of the single markers is not essentially enhanced. Cancer 59:223–226, 1987.This publication has 8 references indexed in Scilit:
- A prospective evaluation of serum carcinoembryonic antigen (CEA) levels in the management of colorectal carcinomaWorld Journal of Surgery, 1984
- Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.Journal of Clinical Pathology, 1984
- Vergleich der Tumormarker CEA und CA 19-9 in der kolorektalen DiagnostikDeutsche Medizinische Wochenschrift (1946), 1984
- Klinische Bedeutung des zirkulierenden tumorassoziierten Antigens CA 19-9 bei Karzinomen des VerdauungstraktesDeutsche Medizinische Wochenschrift (1946), 1984
- Second-look laparotomy based on CEA elevations in colorectal cancerCancer, 1981
- Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigenJournal of Surgical Research, 1980
- Carcinoembryonic Antigen (CEA) as a Prognostic and Monitoring Test in Clinically Complete Resection of Colorectal CarcinomaAnnals of Surgery, 1976